Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 260 Results
Age
Type
Conditions or Disease:

Treatment of Renal Kidney Stones with the Monarch Platform

Jaime Landman

  • OPEN TO ACCRUAL

PhIII, RandomPlacebo-controlled MultiTrial Selinex Mainten Systemic Pa w/P53WildtypeEndometrial Ca

Krishnansu Tewari

  • OPEN TO ACCRUAL

A Phase I Study of KSQ-4279 Alone and in Combination in Patients with Advanced Solid Tumors

Krishnansu Tewari

  • SUSPENDED

PhII Immune Checkpoint Combos w/Axitinib in Pts w/Prev Untreated Local AdvUnresec or Metastatic RCC

Nataliya Mar

  • OPEN TO ACCRUAL

Randomized PhIII Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Meta Colorectal Ca

Fa Chyi Lee

  • OPEN TO ACCRUAL

Pragmatic RandomPhIII Trial Eval Total AblativeThe Pa w/Limited MetaColoRecCa Eval Rad Ablation&Surg

Oliver Eng

  • OPEN TO ACCRUAL

Bone Marrow Mesenchymal Stem Cell for COVID-19 related ARDS

Alpesh Amin

  • OPEN TO ACCRUAL

Ph Ib/II ACR-368 as Monother& Comb w/Gemcitabine in Plat-Res Ovarian Ca Endometrial Adenoca &Urothel

Nataliya Mar

  • OPEN TO ACCRUAL

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)

Stefan Octavian Ciurea

  • OPEN TO ACCRUAL

PhIII Inavolisib+FulvestrantVSAlpelisib+Fulvestrant Pa w/HormoneRecep+ HER2- PIK3CA BreastCa

Ritesh Parajuli

  • OPEN TO ACCRUAL

PhII Consolidation Therapy for Relapsed/Refractory LargeB-CellLympoma or GradeIIIBFollicularLymphoma

Elizabeth A Brem

  • OPEN TO ACCRUAL

PhI/II Study of HM43239 in Patients with Relapsed or Refractory AML

Deepa Jeyakumar

  • OPEN TO ACCRUAL

PhI/II FirstInHuman Study DF9001 Comb w/Nivolumab Pa w/Solid Tumors Selected Indications

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study

Madeleine Pahl

  • OPEN TO ACCRUAL

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen

Ali A Habib

  • OPEN TO ACCRUAL

Pre-Gene Therapy Study in Parkinson’s Disease and Multiple System Atrophy

Nicolas Phielipp

  • OPEN TO ACCRUAL